This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Yi Luo, PhD
Senior Director of New Drug Discovery at Biotheus
Speaker

Profile

Dr. Luo Yi has over ten years of biomedical research experience in the UK, US and Canada. He has published in top journals such as Nature Communications, Current Biology, and Small. In 2019, he joined Biotheus Inc. and was recognized as a high-level talent in Zhuhai City, China. At Biotheus Inc., Dr. Luo has led early-stage oncology program development, overseeing multiple multifunctional antibody projects, four of which are in clinical research, including one entering Phase III pivotal studies. He also directed the early discovery of a bispecific antibody program that secured a significant licensing agreement with a multinational pharmaceutical company.